Needham analyst James Ricchiuti maintained a Hold rating on Proto Labs (PRLB – Research Report) today. The company’s shares closed today at ...
GeoVax Labs (GOVX) announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback